Delivery Order SPE2DB24D1201-SPE2DB25FJCHE
Award Date
4/17/25
Potential Completion Date
4/18/25
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication, with a ceiling value of $11,804.15 and a performance period through May 2, 2025. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL, a diabetes medication. The award has a ceiling value of $2,819.97 and a period of performance through April 30, 2025. The contract is not set-aside and was competed openly. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The contract has a ceiling value of $6,051.67 and a performance period through April 23, 2025. This order is not set aside and represents open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract has a ceiling value of $3,512.52 and a period of performance through May 23, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,722.91, is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a diabetes treatment medication. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication, with a ceiling value of $25,492.82 and a period of performance through April 16, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a diabetes treatment medication. The contract has a ceiling value of $16,174.74 and a period of performance ending on April 22, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a diabetes medication. The contract has a ceiling value of $117,344.56 and a period of performance through April 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,128.12, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a type 2 diabetes medication. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,548.93 contract is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a diabetes medication. The contract has an ultimate completion date of May 28, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...